Today's Date: March 28, 2024
The Pershing Square Foundation Announces $2M in Grants to Newark Organizations to Support Local Community   •   Tetra Tech to Host Inaugural Investor Day on May 14, 2024   •   WellSky® Develops New Clinical Care Certification to Enhance Expertise and Competency in Home Healthcare   •   Health Care Costs Top the List of Financial Worries in Retirement, New Research from eHealth and Retirable Shows   •   Meijer Continues Fight Against Hunger with $2 Million Donation to Midwest Food Bank Partners   •   Milliken & Company Receives A- Climate Change Performance Rating   •   Oka, The Carbon Insurance Company (Oka)™ Closes $10-Million in Funding   •   Tigo Energy Headquarters Receives 90kW of Optimized Solar from Long-Time Installer Partner   •   Phone Fraud and Spam Reached All-Time High, Costing Scammed Consumers Nearly $2,300 on Average in 2023   •   KFC TAKES FINGER LICKIN' GOOD TO A WHOLE NEW LEVEL WITH NEW SAUCY NUGGETS IN FIVE DRIPPING FLAVORS   •   Blain's Farm & Fleet Launches Exclusive Estate 4-in-1 Lawn Fertilizer Redefining the Future of Lawn Care   •   Cisco Sponsors SANS Institute Cohort to Close Cybersecurity Skills Gap   •   Ready. Set. Food! and ObvioHealth Launch Innovative Trial to Correlate Infant Food Allergy Prevention with Reduced Healthcare Co   •   Wolters Kluwer enters nursing test prep market with launch of Lippincott Ready for NCLEX   •   Displate Introduces Textra, A Metal Poster Bringing Art to Life in 3D   •   Contentful Studio Launches, Transforming Digital Team Efficiency While Shortening Time-to-Impact From Months to Minutes   •   Headlands Research Announces Fifth Research Site under Partnership with Pfizer to Improve Diversity in Clinical Trials   •   Northeastern Illinois University Hosting Open House and Latino College Expo April 4   •   Unique online yoga platform offers lifeline for menopausal women   •   Dexian Invests in Tomorrow’s Tech Leaders
Bookmark and Share

The Leukemia & Lymphoma Society Thanks Press On Fund for $100,000 Gift to Support Groundbreaking Pediatric Cancer Research

The Leukemia & Lymphoma Society Thanks Press On Fund for $100,000 Gift to Support Groundbreaking Pediatric Cancer Research

PR Newswire

ATLANTA, June 4, 2020 /PRNewswire/ -- A global leader in the fight against cancer, The Leukemia & Lymphoma Society (LLS) announced today a $100,000 donation by the Press On Fund to support LLS's assault on pediatric cancer.

LLS is working with a team of renowned pediatric oncologists to lay the groundwork for a global precision medicine master clinical trial to match children with relapsed acute leukemia to a targeted therapy based on the specific abnormalities driving their cancer. The goal of the trial is to test multiple targeted therapies simultaneously at up to 200 clinical sites worldwide.

Press On Fund's donation supports this unprecedented clinical trial called LLS PedAL, which is a key component of The LLS Children's Initiative, a comprehensive $100 million multi-year endeavor to take on children's cancer from every direction, including new research grants to advance novel therapies, enhanced free education and support services for children and their families, and renewed policy and advocacy efforts.

"As parents who have experienced this fight first-hand, we know how important LLS PedAL is for children and families everywhere," said Tara Simkins, co-founder of the Press On Fund and mother to Brennan, a childhood cancer survivor. "We are extraordinarily hopeful about this groundbreaking research, offering promise for less toxic and more effective treatment options for children battling cancer."

While many children survive acute lymphoblastic leukemia, the most common type of pediatric blood cancer, the treatments are harsh and outdated. The long-term effects of current therapies can create severe life-threatening complications. And survival rates for children with other high-risk types of leukemia, such as acute myeloid leukemia, are very poor. 

"Our gratitude for the generosity of the Press On Fund and their commitment to our quest to fight pediatric cancer cannot be overstated", said Piper Medcalf, LLS Georgia Chapter Executive Director. "We need this kind of support now, more than ever. For too long, treatment for pediatric cancer has followed a one-size-fits-all approach and we need to do better. With LLS PedAL, we will."

About The Leukemia & Lymphoma Society

The Leukemia & Lymphoma Society® (LLS) is a global leader in the fight against cancer. The LLS mission: cure leukemia, lymphoma, multiple myeloma, and improve the quality of life of patients and their families. LLS funds lifesaving blood cancer research around the world, provides free information and support services, and is the voice for all blood cancer patients seeking access to quality, affordable, coordinated care.

Founded in 1949 and headquartered in Rye Brook, NY, LLS has chapters throughout the United States and Canada. To learn more, visit www.LLS.org. Patients should contact the Information Resource Center at (800) 955-4572, Monday through Friday, 9 a.m. to 9 p.m., ET.

For additional information visit lls.org/lls-newsnetwork. Follow us on Facebook, Twitter, and Instagram.

The LLS Children's Initiative: Cures and Care for Children with Cancer

The LLS Children's Initiative is a $100 million multi-year effort to take on children's cancer through every facet of LLS's mission: research, patient education and support and policy and advocacy. The LLS Children's Initiative includes: more pediatric research grants, a global precision medicine clinical trial, expanded free education and support services for children and families and driving policies and laws that break down barriers to care. To learn more, visit www.lls.org/childrens-initiative.

About Press On Fund

Press On's unique mission is to identify feasible and groundbreaking alternative therapies for childhood cancers and to invest monies raised in a manner that supports the science and infrastructure needed to cure childhood cancer within our lifetime. Press On, created in 2006, is made up of four families whose lives were connected by childhood cancer and saw a need for additional funding for childhood cancer research.  Press On is a field of interest fund of the Community Foundation for the CSRA and uses a 100% donation model.  To learn more, visit www.pressonfund.org.  Press On Fund's social media handles: Facebook, Twitter, and Instagram @wepresson

Contact: Andrea Greif

Vice President, Communications

The Leukemia & Lymphoma Society

(914) 821-8958

andrea.greif@lls.org

Contact:

Piper Medcalf, Executive Director

Piper.Medcalf@lls.org

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/the-leukemia--lymphoma-society-thanks-press-on-fund-for-100-000-gift-to-support-groundbreaking-pediatric-cancer-research-301071059.html

SOURCE The Leukemia & Lymphoma Society (LLS)



Back to top
| Back to home page
Video

White House Live Stream
LIVE VIDEO EVERY SATURDAY
alsharpton Rev. Al Sharpton
9 to 11 am EST
jjackson Rev. Jesse Jackson
10 to noon CST


Video

LIVE BROADCASTS
Sounds Make the News ®
WAOK-Urban
Atlanta - WAOK-Urban
KPFA-Progressive
Berkley / San Francisco - KPFA-Progressive
WVON-Urban
Chicago - WVON-Urban
KJLH - Urban
Los Angeles - KJLH - Urban
WKDM-Mandarin Chinese
New York - WKDM-Mandarin Chinese
WADO-Spanish
New York - WADO-Spanish
WBAI - Progressive
New York - WBAI - Progressive
WOL-Urban
Washington - WOL-Urban

Listen to United Natiosns News